Skip to main content
. 2024 Mar 4;24:79. doi: 10.1186/s12893-024-02375-6

Table 1.

Baseline clinical characteristics of 315 ATC patients with DM

No. patients (%)
Gender
 Female 160 (50.79%)
 Male 155 (49.21%)
Age at diagnosis
 Median[min-max] 70.00[23.00,90.00]
Race
 Non-Hispanic White 182 (57.78%)
 Hispanic White 53 (16.83%)
 Black 20 (6.35%)
 Others 60 (19.05%)
T Stage 1
 T1/2 17 (5.40%)
 T3 66 (20.95%)
 T4 232 (73.65%)
N Stage
 N0 79 (25.08%)
 N1 236 (74.92%)
Tumor Diameter
 ≤ 6 cm 123 (39.05%)
 > 6 cm 192 (60.95%)
Tumor Extension
 Limited to Thyroid 65(20.63%)
 Extrathyroidal Extension 250 (79.37%)
Distant Lymph Node Metastasis
 No 215(68.25%)
 Yes 100(31.75%)
Bone Metastasis
 No 246(78.10%)
 Yes 69(21.90%)
Brain Metastasis
 No 296(93.97%)
 Yes 19(6.03%)
Liver Metastasis
 No 287(91.11%)
 Yes 28(8.89%)
Lung Metastasis
 No 49(15.56%)
 Yes 266(84.44%)
Multiple Organ Metastases
 No 244(77.46%)
 Yes 71(22.54%)
Marital status
 Single (never married) 40(12.70%)
 Married 189(60.00%)
 Divorced/Separated/Widowed 83(26.35%)
 Unknown 3(0.95%)
Surgery to Primary Site
 No 202 (64.13%)
 Non-thyroidectomy 35 (11.11%)
 Thyroidectomy 78 (24.76%)
Radiotherapy
 No 132 (41.90%)
 Yes 183 (58.10%)
Chemotherapy
 No 166 (52.70%)
 Yes 149 (47.30%)

1 Refined to AJCC 8th edition according to tumor extension and tumor diameter